Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a...

Piper Sandler analyst David Westenberg maintains Tempus AI (NASDAQ:TEM) with a Neutral and lowers the price target from $105...

Morgan Stanley analyst Tejas Savant maintains Tempus AI (NASDAQ:TEM) with a Overweight and raises the price target from $68 ...

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers the price target from $98 to ...

Congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.) has announced she will not seek re-election in the 2026 e...

Canaccord Genuity analyst Kyle Mikson maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers the price target from $110 to $95.

Tempus AI beats Q3 revenue estimates with $334.21M, narrows adjusted loss to $0.11 per share, and raises FY25 guidance to $1.265B.